Folic acid meeting
This article was originally published in The Tan Sheet
Executive Summary
Centers for Disease Control and Prevention schedules on Aug. 11 public meeting to gather input on establishing a surveillance program to "monitor possible adverse effects of increased folate consumption, with emphasis on the possibilities for complicating the diagnosis of pernicious anemia and other vitamin B[12] deficiencies," CDC announced in a July 27 Federal Register notice. The surveillance program is in response to an October 1992 PHS recommendation that women of childbearing age should consume 400 mcgs of folic acid daily to reduce their risk of conceiving a child with neural tube defects, an idea endorsed by FDA's Folic Acid Subcommittee ("The Tan Sheet" April 19, p. 3). The meeting will convene at 8:30 a.m. in Auditorium B of CDC headquarters in Atlanta.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning